Posted by Anon on October 18, 1999, at 10:56:58
In reply to Reboxetine "Approvable", posted by JohnL on October 17, 1999, at 5:27:53
Reboxetine appears to be an antidepressant with great potential. It has indeed received an 'Approvable' letter.
That does _ NOT_ mean Pharmacia & Upjohn will actually sell it to the public anytime soon.
Why? Well, the FDA is concerned enough about one of its side effects to ask for physician monitoring of this side effect while the patient is taking Reboxetine. No general physician or family practicioner in his/her right mind will prescribe Reboxetine if they have to monitor the patient. Better to give the patient Prozac or whatever and not be concerned with monitoring this certain vital sign. Thus, the business potential of Reboxetine is greatly reduced. Pharmacia & Upjohn is now squabbling with the FDA to get this restriction removed (it appears to be a statistical fluke).
Reboxetine might, at best, be launched next year.
It may never be launched.
Sorry....
poster:Anon
thread:13305
URL: http://www.dr-bob.org/babble/19991016/msgs/13367.html